Chronic Disease (number of patients with MI) | Mean LOS in days in scenarios of 1. Without MI (SD) and 2. With MI (SD) | Type of MIa (number of patients with the type of MI) | Mean LOS (SD) in days for patients with this type of MI | Adjusted LOS variationb: % increase in mean LOS with MI (95% CI) | Difference in Bed-days’ usec | |
---|---|---|---|---|---|---|
Per patient | in 5 years | |||||
Cancer (n= 100) | Scenario 1: 8.6 (9.3) Scenario 2**: 12.8 (11.8) | F10–F19 Mental and behavioural disorders due to psychoactive substance use (n = 48) | 9.5 (7.4) | 14.6% (–14.3%–53.2%) | NA | NA |
All other subtypes (n = 52) | 15.8 (14.1) | 97.0% (49.9%–159%) | 7.8 | 404 | ||
COPD( n= 320) | Scenario 1: 4.3 (4.6) Scenario 2*: 4.9 (4.6) | F40–F48 Neurotic, stress-related and somatoform disorders (n = 102) | 6.2 (5.2) | 64.2% (39.4%–93.4%) | 2.4 | 248 |
All other subtypes (n = 218) | 4.3 (4.1) | 8.2% (–4.7%–22.9%) | NA | NA | ||
Diabetes (n = 90) | Scenario 1: 5.6 (9.3) Scenario 2**: 8.7 (8.5) | All (n = 90) | 8.7 (8.5) | 68.0% (29.6%–118%) | 3.5 | 317 |
IHD (n = 250) | Scenario 1: 3.2 (4.1) Scenario 2**: 6.2 (9.6) | All (n = 250) | 6.2 (9.6) | 90.5% (71.5%–112%) | 2.9 | 735 |
Stroke (n= 286) | Scenario 1: 7.9 (10.8) Scenario 2**: 16.7 (26.7) | F10–F19 Mental and behavioural disorders due to psychoactive substance use (n = 151) | 12.5 (28.1) | 36.3% (16.2%–59.9%) | 3.3 | 505 |
All other subtypes (n = 135) | 21.3 (24.4) | 109% (78%–146%) | 11.1 | 1502 |